1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow NC 6300: new trials by email Literature Review of NC 6300 trials Research Report on NC 6300
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma NC 6300 - Solid Tumor, Soft Tissue Sarcoma | Phase 1 / Phase 2 | Unknown | NanoCarrier Co., Ltd. | 150 | 2017-06-30 | 2020-02-28 |
Sarcoma (1)
United States (1)
Atsushi Osada (1)